No definition available.
Disorders of myoneural junction and muscle in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
G6_MYOMUSCINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
270 |
4. Check minimum number of eventsNone |
270 |
5. Include endpointsNone |
270 |
6. Filter based on genotype QC (FinnGen only) |
270 |
Control definitions (FinnGen only)
- Control exclude
- G6_MYONEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of myoneural junction and muscle in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Diseases of the myoneural junction and muscle
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1357 | 973 | 377 |
| Only index persons | 1184 | 865 | 319 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.01 |
| Only index persons | 0.03 | 0.03 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 61.99 | 62.44 | 60.81 |
| Only index persons | 61.00 | 61.15 | 60.58 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 270 | 204 | 66 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.03 |
| Median age at first event (years) | 57.26 | 56.19 | 60.59 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 247
- Matched controls
- 2468
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
99.9
89
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
96.2
92.7
99
17
P01BA02
ATC
hydroxychloroquine; oral
19.6
71.6
118
110
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
13.8
60.2
117
151
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
+∞
46.3
43
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
115.6
44.6
47
5
L04AX01
ATC
azathioprine; systemic
18.9
39.5
62
43
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.7
31.7
65
80
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
30.9
29
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.2
27.5
61
85
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
84.7
27.4
30
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
7.1
24.8
66
121
M05BA04
ATC
alendronic acid; oral
7.6
24.7
62
104
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
62.8
24.6
28
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.2
24.5
140
590
H02AB07
ATC
prednisone; oral
5.3
24.2
86
226
H02AB06
ATC
prednisolone; systemic
4.0
23.0
170
881
G73.0*E05.9
ICD-10 Finland
Myasthenic syndromes in thyrotoxicosis [hyperthyroidism]
+∞
22.2
21
*
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
114.3
19.9
21
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
216.6
19.9
20
*
L04AA06
ATC
mycophenolic acid; systemic
25.1
19.5
27
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
19.5
151
766
G73.1*C80.99
ICD-10 Finland
Eaton-Lambert syndrome
+∞
19.0
18
*
G73.0*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic amyotrophy
+∞
17.9
17
*
N07AA02
ATC
pyridostigmine; systemic
+∞
17.9
17
*
H02AB04
ATC
methylprednisolone; systemic
4.3
16.7
70
209
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.4
16.5
45
83
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
14.7
14
*
G73.0*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic amyotrophy
+∞
14.7
14
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.9
14.5
50
121
G73.7*M34.8
ICD-10 Finland
Myopathy in scleroderma
+∞
13.7
13
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
147.8
13.6
14
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.8
13.3
142
810
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.6
13.2
31
46
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
4.0
12.6
54
161
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
8.5
12.5
27
35
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
12.4
102
491
H04.10
ICD-10 Finland
Dry eye syndrome
4.0
12.3
52
153
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.7
12.1
31
52
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.2
11.7
47
132
G73.7*M05.3
ICD-10 Finland
Rheumatoid myopathy
125.6
11.5
12
*
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
125.6
11.5
12
*
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
125.6
11.5
12
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.2
11.2
44
121
C03CA01
ATC
furosemide; systemic
2.8
11.2
89
414
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
9.5
11.0
22
25
M32
ICD-10 Finland
Systemic lupus erythematosus
114.7
10.5
11
*
G70.0
ICD-10 Finland
Myasthenia gravis
+∞
10.5
10
*
L88
ICPC
Rheumatoid/seropositive arthritis
7.3
10.2
24
36
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.2
10.0
19
20
M35.1
ICD-10 Finland
Other overlap syndromes
27.3
9.9
13
5
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
57.3
9.7
11
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.0
9.7
31
69
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
31.4
9.5
12
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
103.8
9.5
10
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
9.4
71
315
108
Kela drug reimbursment
Myasthenia gravis
+∞
9.4
9
*
N06AA09
ATC
amitriptyline; systemic
3.4
9.0
45
151
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
8.1
8.8
19
25
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.5
8.8
31
77
N03AX16
ATC
pregabalin; oral
2.5
8.6
81
403
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
5.9
8.5
23
42
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
8.5
37
111
M33.2
ICD-10 Finland
Polymyositis
93.1
8.5
9
*
NXL00
NOMESCO Finland
Biopsy of muscle
93.1
8.5
9
*
C08CA05
ATC
nifedipine; systemic
4.3
8.4
31
80
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
7.5
8.4
19
27
S01KA02
ATC
hypromellose; ophthalmic
10.0
8.4
16
17
G73.1
ICD-10 Finland
Lambert-Eaton syndrome
+∞
8.4
8
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
8.3
50
192
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.6
8.2
38
120
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.6
8.2
28
67
R06.0
ICD-10 Finland
Dyspnoea
2.4
8.2
79
398
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
8.2
71
339
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.7
8.1
35
105
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
8.2
8.0
17
22
N03AX12
ATC
gabapentin; oral
2.8
8.0
55
228
L04AA01
ATC
[U] ciclosporin; systemic
9.9
7.9
15
16
SBA10
NOMESCO Finland
Measurement of excretion of saliva
15.7
7.8
12
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.5
7.8
36
114
ELA30
NOMESCO Finland
Biopsy of salivary gland
46.5
7.8
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
7.7
38
127
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
6.8
7.6
18
28
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.1
7.5
28
74
N06AX21
ATC
duloxetine; oral
3.0
7.3
42
156
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.9
7.3
23
51
R50.9
ICD-10 Finland
Fever, unspecified
2.9
7.2
46
183
H26.3
ICD-10 Finland
Drug-induced cataract
31.0
7.2
9
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
12.5
7.2
12
10
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
7.4
7.1
16
23
A02BC02
ATC
pantoprazole; systemic
2.1
7.0
174
1308
J01FF01
ATC
clindamycin; systemic
2.3
7.0
78
419
E0000UV
ATC
NA
2.1
7.0
110
686
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
6.9
43
168
L93.0
ICD-10 Finland
Discoid lupus erythematosus
41.2
6.8
8
*
L28
ICPC
Limited function/disability (L)
2.6
6.8
51
223
F34.1
ICD-10 Finland
Dysthymia
6.8
6.8
16
25
K11.2
ICD-10 Finland
Sialoadenitis
5.8
6.8
18
33
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.6
6.7
22
51
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
6.6
64
319
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.2
6.6
15
22
A10AA01
ATC
NA
7.2
6.6
15
22
M79.7
ICD-10 Finland
Fibromyalgia
5.0
6.6
20
43
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
6.6
36
127
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
4.7
6.5
21
48
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
71.6
6.5
7
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
14.8
6.4
10
7
S97
ICPC
Chronic ulcer skin
4.7
6.3
20
45
J02AC01
ATC
fluconazole; systemic
2.0
6.3
121
805
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.9
6.3
25
70
P01BA01
ATC
chloroquine; systemic
18.6
6.3
9
5
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
18.6
6.3
9
5
SBB10
NOMESCO Finland
Teeth copy
4.0
6.3
24
65
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
N16.4*M32.1
ICD-10 Finland
Renal tubulo-interstitial disorders in systemic lupus erythematosus
+∞
6.3
6
*
R03CA02
ATC
ephedrine; oral
+∞
6.3
6
*
G73.0
ICD-10 Finland
Myasthenic syndromes in endocrine diseases
+∞
6.3
6
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.9
6.3
19
41
J01MA12
ATC
levofloxacin; systemic
2.4
6.2
55
261
H03AA01
ATC
levothyroxine sodium; systemic
2.1
6.2
79
446
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.3
6.1
30
100
UJF30
NOMESCO Finland
Ileoscopy through colon
3.1
6.1
34
122
M01AX17
ATC
nimesulide; oral
2.2
6.1
72
391
M01AH02
ATC
rofecoxib; oral
2.7
6.1
44
186
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.4
6.0
54
259
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
72
75
12.73
64.89
5.3
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
68
67
13.23
63.52
1.6
1.3
u/ml
6.7
1.8
—
28
10
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
68
68
13.03
62.88
1.7
1.3
u/ml
2.4
2.1
0.30
31
12
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
59
55
13.45
56.84
1.6
1.3
u/ml
21.3
13.7
—
12
6
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
53
56
11.53
46.65
1.5
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
108
305
5.23
37.37
1.7
1.4
titre
1219.0
504.5
2.51
59
75
(42870588) Differential panel, method unspecified - Blood
174
727
4.92
36.32
11.4
5.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
75
165
5.91
34.25
4.3
2.6
g/l
11.3
10.1
1.07
64
154
(3004616) Nuclear Ab [Presence] in Serum
35
33
12.04
32.89
1.4
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
54
9.03
31.55
1.6
1.3
u/ml
63.7
35.9
—
11
9
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
28
22
14.08
29.32
1.4
1.2
u/ml
2.6
—
—
5
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
28
23
13.47
28.55
1.4
1.2
u/ml
59.1
94.4
—
7
5
(3019069) Monocytes/100 leukocytes in Blood
195
1061
4.02
24.50
13.4
5.7
%
8.9
8.5
1.04
190
984
(3001604) Monocytes [#/volume] in Blood
202
1127
4.15
24.41
12.9
5.4
e9/l
0.6
0.6
0.37
186
973
(3006504) Eosinophils/100 leukocytes in Blood
194
1055
3.98
24.32
13.0
5.4
%
2.8
2.7
0.08
189
972
(3006315) Basophils [#/volume] in Blood
202
1131
4.12
24.19
12.9
5.4
e9/l
0.0
0.0
0.17
186
976
(3002030) Lymphocytes/100 leukocytes in Blood
197
1086
4.01
24.11
13.2
5.6
%
26.0
28.3
2.49
191
1002
(3022096) Basophils/100 leukocytes in Blood
190
1024
3.89
24.04
13.2
5.4
%
0.7
0.7
0.25
185
942
(3019198) Lymphocytes [#/volume] in Blood
203
1153
4.07
23.49
12.8
5.4
e9/l
1.6
1.9
3.63
187
1023
(3013115) Eosinophils [#/volume] in Blood
204
1170
4.04
23.08
13.6
5.7
e9/l
0.2
0.2
0.03
186
1027
(3018010) Neutrophils/100 leukocytes in Blood
194
1077
3.85
23.07
12.5
5.3
%
59.5
57.1
2.13
188
1001
(3023420) DNA double strand Ab [Units/volume] in Serum
25
25
10.92
22.38
5.0
1.3
iu/ml
26.4
—
—
7
0
(3028026) IgM [Mass/volume] in Serum or Plasma
54
140
4.57
19.71
2.3
1.7
g/l
1.2
1.4
0.28
45
129
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
11
16.43
19.51
1.1
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
121
4.73
18.96
7.3
3.3
mmol/l
1.5
1.9
0.21
40
93
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
135
664
3.07
18.27
4.4
1.9
u/l
323.5
148.3
0.51
130
630
(3013650) Neutrophils [#/volume] in Blood by Automated count
209
1327
3.54
17.85
16.1
9.3
e9/l
4.0
4.0
0.15
193
1163
(3009343) pH of Capillary blood
49
127
4.49
17.81
7.6
3.2
ph
7.4
7.4
—
9
13
(3020779) Urea [Moles/volume] in Serum or Plasma
55
157
4.14
17.61
11.0
6.6
mmol/l
10.7
9.4
0.71
50
146
(3020630) Protein [Mass/volume] in Serum or Plasma
55
166
3.91
16.23
1.9
3.0
g/l
64.0
67.3
1.95
47
152
(3004588) Protein electrophoresis panel - Serum or Plasma
51
147
4.04
16.04
2.0
2.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
115
557
2.85
15.43
6.2
3.8
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
111
530
2.86
15.27
3.1
2.1
mg/l
3.5
3.2
0.73
97
454
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
166
985
2.78
14.81
3.3
2.3
nmol/l
81.7
78.3
0.72
153
869
(3023520) Reticulocytes [#/volume] in Blood
52
166
3.64
14.05
2.3
2.8
e9/l
61.2
71.7
1.56
38
133
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
169
1031
2.71
13.96
10.0
5.3
mmol/l
1.2
1.2
0.28
159
924
(3003458) Phosphate [Moles/volume] in Serum or Plasma
67
256
3.15
13.57
11.9
5.0
mmol/l
1.1
1.0
0.09
61
230
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
35
6.75
13.50
3.5
3.4
%
56.3
61.4
0.70
22
35
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
35
6.75
13.50
3.4
2.9
e9/l
3.6
5.2
1.42
22
35
(3012095) Magnesium [Moles/volume] in Serum or Plasma
79
335
2.92
13.30
3.2
2.9
mmol/l
0.8
0.8
0.56
70
316
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
78
334
2.88
12.85
2.3
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
63
240
3.12
12.77
2.4
3.0
%
1.7
1.8
0.22
57
219
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
175
1122
2.59
12.49
12.1
6.2
mmol/l
1.2
1.2
0.32
148
949
(3002179) Metamyelocytes/100 leukocytes in Blood
48
158
3.48
12.31
4.9
4.8
%
0.5
0.5
0.06
25
37
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
135
778
2.47
11.98
6.5
3.1
—
—
—
0
0
(3013512) EKG study
119
649
2.49
11.89
4.8
3.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
90
4.18
11.88
2.3
2.3
g/l
1.8
1.7
0.24
27
77
(3002582) Erythrocytes [#/volume] in Urine
121
669
2.47
11.69
5.2
3.1
e6/l
26.3
150.9
0.69
99
509
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
58
221
3.07
11.69
2.9
4.6
u/l
260.0
240.5
0.75
52
209
(3015377) Calcium [Moles/volume] in Serum or Plasma
136
796
2.43
11.54
3.6
3.3
mmol/l
2.3
2.4
0.67
118
697
(3022313) Gas panel - Capillary blood
34
92
4.08
11.53
9.4
3.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
48
167
3.28
11.24
5.3
4.7
%
0.0
0.1
1.49
27
49
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
31
80
4.25
11.19
2.4
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
94
471
2.53
11.14
4.8
2.5
e6/l
4.4
6.9
0.66
84
412
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
19
8.30
11.12
1.3
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
21
40
5.61
10.77
1.6
1.4
—
—
—
0
0
(4268621)
17
26
6.91
10.76
2.0
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
133
789
2.35
10.73
6.0
3.7
e6/l
70.8
68.7
0.02
104
546
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
35
102
3.79
10.71
1.8
2.2
u/l
44.0
40.3
0.39
30
90
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
25
57
4.73
10.50
1.2
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
45
158
3.22
10.35
5.2
4.8
%
0.0
0.0
0.00
26
41
(1616796) Gas panel - Central venous blood
21
42
5.34
10.22
4.3
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
23
50
4.94
10.21
1.6
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
70
316
2.64
10.19
2.6
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
87
3.90
9.98
2.7
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
179
3.05
9.96
5.3
4.6
%
0.7
0.9
0.23
27
57
(3032080) INR in Blood by Coagulation assay
142
886
2.27
9.94
9.2
7.8
inr
1.2
1.2
0.12
35
258
(3013707) Erythrocyte sedimentation rate by Westergren method
223
1693
2.82
9.94
11.6
4.1
mm/h
17.2
12.1
5.11
215
1546
(3019225) pH of Specimen
56
229
2.82
9.84
8.0
4.1
—
—
—
0
0
(4062490)
14
19
7.72
9.79
1.6
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
72
336
2.56
9.75
3.8
2.3
umol/l
10.5
13.7
3.45
66
308
(3007853) Bacteria identified in Skin by Aerobe culture
58
244
2.75
9.65
2.3
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
229
1774
2.92
9.59
14.9
7.1
u/l
75.5
78.3
0.54
224
1646
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
45
4.98
9.47
2.2
1.7
g/l
124.6
129.7
0.33
13
30
(3037467) Urinalysis macro (dipstick) panel - Urine
209
1553
2.53
9.47
11.4
4.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
34
5.60
9.29
1.3
1.1
u/ml
2.9
1.2
—
9
9
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
38
5.30
9.24
1.3
1.1
u/ml
3.7
4.4
0.14
11
16
(3024561) Albumin [Mass/volume] in Serum or Plasma
149
969
2.20
9.18
7.5
4.0
g/l
34.1
35.8
2.83
135
905
(3020876) Protein [Mass/time] in 24 hour Urine
11
12
9.51
9.04
2.0
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
107
613
2.23
9.01
5.4
2.9
e6/l
0.3
0.5
0.82
86
448
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
14
21
6.98
8.98
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
14
21
6.98
8.98
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
14
21
6.98
8.98
1.3
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
19
39
5.16
8.98
2.8
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
74
3.94
8.97
4.4
3.0
g/l
0.5
0.2
0.92
14
22
(36304419) Bacteria [Presence] in Urine
105
599
2.23
8.92
5.5
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
25
65
4.14
8.91
3.5
2.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
37
128
3.19
8.68
3.3
3.6
pmol/l
3.9
4.5
2.28
32
108
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
14
22
6.66
8.61
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
14
22
6.66
8.61
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
14
22
6.66
8.61
1.3
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
149
987
2.14
8.54
3.9
2.7
ug/l
152.6
99.4
1.76
134
906
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
6
20.83
8.54
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
6
20.83
8.54
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
6
20.83
8.54
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
6
20.83
8.54
1.1
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
19
41
4.91
8.49
5.0
2.4
mmol/l
2.0
2.6
0.48
12
25
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
140
909
2.12
8.42
2.3
2.0
pmol/l
101.6
96.6
0.57
78
454
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
62
289
2.49
8.31
4.3
2.3
%
20.1
23.1
0.97
54
245
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
23
6.37
8.26
3.3
3.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
14
23
6.37
8.26
1.7
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
159
1091
2.11
8.18
5.8
3.7
estimate
0.0
0.0
0.00
35
207
(3004789) Transferrin [Mass/volume] in Serum or Plasma
64
305
2.44
8.17
4.1
2.2
g/l
2.1
2.4
2.56
58
280
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
108
643
2.13
8.08
5.0
3.1
ng/l
2743.4
1148.3
1.23
91
535
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
31
5.42
8.03
1.3
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
39
4.87
8.00
9.4
5.2
iu/ml
1900.0
139.8
—
5
5
(46235355) HIV 1 and 2 tests - Meaningful Use set
65
316
2.39
7.92
1.8
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
222
2.60
7.85
1.8
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
44
4.57
7.81
1.4
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
6
19.03
7.66
1.5
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
11
15
7.60
7.61
2.6
1.9
e9/l
0.8
0.9
—
6
6
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
37
4.84
7.51
1.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
159
1113
2.04
7.49
6.0
3.7
estimate
0.0
0.0
0.00
31
197
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
50
4.24
7.49
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
78
421
2.20
7.39
4.9
2.6
mosm/kgh2o
461.8
546.5
2.95
70
351
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
58
276
2.40
7.38
1.8
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
129
842
2.02
7.36
6.1
3.6
ng/l
44.5
37.3
0.23
96
573
(3034860) Kappa light chains.free [Mass/volume] in Serum
23
65
3.77
7.32
1.9
4.5
mg/l
45.6
165.2
0.66
17
53
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
23
65
3.77
7.32
1.9
4.6
mg/l
32.4
28.1
0.36
16
53
(40768443) Skin Pathology biopsy report
30
102
3.18
7.23
1.3
1.2
—
—
—
0
0
(3010421) pH of Blood
19
48
4.18
7.02
5.4
2.6
ph
7.4
7.4
0.07
19
40
(3021601) Nitrite [Presence] in Urine by Test strip
156
1102
1.98
6.97
7.6
4.9
estimate
0.0
0.0
0.00
34
207
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
53
4.00
6.94
1.6
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
83
3.36
6.92
1.8
2.2
g/l
3.2
3.2
0.07
16
68
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
49
4.10
6.83
1.4
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
343
2.22
6.81
1.4
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
28
5.22
6.78
1.4
1.6
—
—
—
0
0
(3015736) pH of Urine
127
842
1.96
6.77
5.1
3.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
74
3.46
6.73
1.7
1.4
ug/g
313.1
324.9
0.12
16
40
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
21
5.93
6.64
2.0
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
37
4.53
6.58
1.3
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
16
37
4.53
6.58
1.4
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
181
2.56
6.56
6.5
3.4
ng/l
113.4
82.3
0.98
33
158
(3018418) pH of Serum or Plasma
110
700
1.96
6.56
8.0
3.7
ph
7.4
7.4
0.51
25
124
(3017732) Neutrophils [#/volume] in Blood
39
164
2.61
6.40
3.3
2.3
e9/l
3.3
4.1
0.97
27
122
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
89
530
2.01
6.39
1.5
1.3
u/ml
3.5
1.6
0.26
17
145
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
15
6.88
6.35
1.4
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
22
5.66
6.34
1.5
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
34
4.61
6.32
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
75
421
2.08
6.32
2.3
1.7
nmol/l
1261.5
1143.5
0.56
61
312
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
26
5.20
6.29
1.4
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
39
4.30
6.18
1.4
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
81
473
2.02
6.10
2.3
1.4
g/l
2.7
2.4
0.52
54
271
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
90
3.09
6.08
1.8
2.2
g/l
3.6
3.9
0.43
16
68
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
90
3.09
6.08
1.8
2.2
g/l
7.1
7.6
0.58
17
70
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
90
3.09
6.08
1.8
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
103
2.92
5.90
1.6
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
24
5.19
5.80
2.0
1.8
—
—
—
0
0
(4035726)
46
219
2.33
5.79
1.3
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
17
46
3.88
5.74
2.6
1.5
e6/l
2580.5
22331.0
0.83
11
30
(40760888) Immunoglobulin light chains.free panel - Serum
17
46
3.88
5.74
1.8
5.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
56
3.57
5.70
1.9
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
38
167
2.48
5.69
1.8
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
90
560
1.91
5.57
3.6
2.8
umol/l
353.8
5894.5
2.22
76
481
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
23
78
3.13
5.56
2.0
2.6
g/l
0.2
0.9
1.37
17
70
(3005322) IgE [Units/volume] in Serum or Plasma
32
131
2.64
5.53
1.3
1.2
u/ml
309.3
350.6
0.06
26
118
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
86
531
1.91
5.43
2.9
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
114
2.73
5.42
1.6
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
108
718
1.84
5.41
3.2
2.3
u/l
55.0
56.7
0.23
96
659
(40758558) Short blood count panel - Blood
91
574
1.88
5.38
10.9
7.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
72
420
1.97
5.37
1.3
1.3
iu/ml
49.3
30.5
0.86
31
141
(3042631) Mycobacterium sp identified in Specimen
13
30
4.50
5.35
2.7
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
30
4.50
5.35
1.4
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
57
306
2.09
5.33
4.2
4.3
%
32.6
32.6
0.01
42
194
(3033658) Prothrombin time (PT) actual/Normal
88
554
1.87
5.20
5.3
3.3
%
93.4
94.7
0.18
88
544
(3044941) Cell count panel - Synovial fluid
12
27
4.60
5.09
1.5
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
105
706
1.80
4.98
3.0
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
85
537
1.85
4.94
1.5
1.5
nmol/l
21.7
22.1
0.08
73
444
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
23
85
2.86
4.82
1.9
2.2
g/l
11.0
10.5
0.13
16
75
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
159
1216
1.75
4.74
6.7
5.7
umol/l
9.0
10.6
2.43
148
1152
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
21
75
2.95
4.67
2.0
2.3
g/l
36.0
37.7
0.45
15
66
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
80
505
1.83
4.62
2.2
1.6
mg/l
1.2
1.0
0.39
63
402
(3021788) Differential panel - Synovial fluid
13
34
3.97
4.59
2.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
54
3.29
4.57
3.5
2.3
u/ml
0.2
0.4
—
9
26
(3034426) Prothrombin time (PT)
8
8
10.26
4.55
1.0
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
166
1294
1.73
4.54
7.2
4.3
mmol/l
6.5
6.6
0.18
157
1204
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
119
2.51
4.50
1.8
1.7
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
18
60
3.14
4.49
1.1
1.1
—
10.8
—
0
8
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
141
1054
1.71
4.47
4.0
3.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
53
295
1.99
4.46
1.7
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
91
604
1.76
4.42
6.5
4.0
estimate
0.0
0.0
0.00
32
208
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
43
224
2.09
4.32
1.6
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
56
3.17
4.32
2.3
1.6
iu/l
10.3
5.7
—
6
18
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
9
9.12
4.31
1.9
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
9
9.12
4.31
1.9
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
9
9.12
4.31
1.9
2.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
71
442
1.82
4.25
2.9
2.7
mmol/l
2.5
2.5
0.01
62
391
(3021589) Normoblasts [#/volume] in Blood
133
993
1.67
4.13
20.9
9.0
e9/l
0.0
0.0
0.25
114
805
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
210
1776
1.82
4.06
5.9
4.1
pmol/l
15.2
14.8
1.65
190
1599
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
43
3.38
3.96
5.8
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
36
181
2.14
3.96
8.0
3.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
15
6.17
3.85
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
16
55
3.03
3.80
2.9
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
8
8.94
3.79
1.4
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
72
465
1.75
3.77
1.6
1.8
pmol/l
471.5
470.9
0.01
58
384
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
59
361
1.81
3.70
4.0
2.6
e6/l
0.6
1.0
1.54
37
194
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
230
1.98
3.69
1.9
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
101
721
1.64
3.63
3.3
2.9
u/l
30.6
28.9
0.39
93
687
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
9
7.95
3.58
1.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
203
2.01
3.57
5.1
3.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
63
2.81
3.56
4.1
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
63
2.81
3.56
1.4
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
31
3.66
3.52
1.2
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
75
501
1.69
3.45
9.1
5.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
99
711
1.62
3.44
4.1
2.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
75
503
1.68
3.40
5.8
3.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
10
7.15
3.38
1.4
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
32
3.54
3.37
1.1
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
63
404
1.73
3.36
1.3
1.3
u/ml
17.5
10.9
0.17
15
150
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
137
2.16
3.30
1.4
1.5
—
—
—
0
0
(4010399)
33
173
2.03
3.27
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
15
5.46
3.21
2.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
15
5.46
3.21
2.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
15
5.46
3.21
2.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
15
5.46
3.21
2.3
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
47
280
1.82
3.20
7.5
6.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
94
677
1.60
3.18
5.1
3.0
mmol/l
6.8
7.1
0.33
78
562
(3027456) Digoxin [Moles/volume] in Serum or Plasma
13
44
3.05
3.18
2.6
3.2
nmol/l
0.9
1.0
—
8
35
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
33
176
2.00
3.12
7.3
3.6
mmol/l
1.2
1.2
0.37
28
158
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
16
62
2.68
3.10
1.6
2.1
mg/l
10.8
12.0
0.26
16
56
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
16
5.12
3.07
1.1
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
5
10.15
2.99
1.8
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
41
240
1.84
2.96
7.1
6.5
mmol/l
0.9
1.3
0.16
32
195
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
17
4.81
2.94
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
34
188
1.92
2.91
2.1
2.4
ug/l
3.7
6.2
0.77
24
166
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
22
4.19
2.91
1.1
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
9
22
4.19
2.91
2.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
9
22
4.19
2.91
2.1
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
9
22
4.19
2.91
2.1
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
26
132
2.07
2.81
5.3
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
177
1495
1.53
2.79
4.6
2.9
u/l
52.4
46.0
0.44
163
1398
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
6
8.46
2.76
1.0
1.2
%
106.4
103.2
—
5
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
6
8.46
2.76
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
6
8.46
2.76
1.0
1.0
miu/ml
1752.0
1828.2
—
5
6
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
14
5.10
2.74
1.4
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
10
6.11
2.71
3.2
2.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
19
4.31
2.70
4.1
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
33
187
1.87
2.64
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.25
2.56
1.2
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
32
182
1.86
2.53
6.3
3.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
87
644
1.52
2.53
5.4
3.1
mg/l
1661.0
143.1
0.76
58
395
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
333
1.66
2.52
4.1
2.8
e6/l
3.9
2.9
0.32
30
168
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
39
2.90
2.50
1.1
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
21
3.89
2.48
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
90
675
1.50
2.45
6.6
3.9
mg/mmol
18.6
6.7
1.58
57
403
(1761868) Lipid panel - Serum or Plasma
59
823
0.64
2.41
4.0
2.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
27
3.41
2.41
1.1
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
6
12
5.09
2.41
1.2
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
8
6.34
2.38
3.2
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
8
6.34
2.38
6.4
5.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
17
4.20
2.37
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
13
4.69
2.28
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
13
4.69
2.28
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
18
3.96
2.26
1.9
2.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
9
29
3.17
2.24
2.8
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
244
2262
1.82
2.23
34.3
13.1
mg/l
23.4
22.1
0.22
222
1764
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
24
3.40
2.19
1.4
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
19
3.75
2.16
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
19
3.75
2.16
1.9
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
19
3.75
2.16
1.9
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
25
3.27
2.11
1.8
1.5
pg
32.3
32.4
—
8
25
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
25
3.27
2.11
1.4
1.0
—
—
—
0
0
(4306422)
9
31
2.97
2.09
1.1
1.2
—
—
—
0
0
(4211845)
5
10
5.07
2.08
6.4
4.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
15
4.07
2.05
1.2
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
42
278
1.60
1.97
39.6
19.9
inr
1.4
1.3
—
6
43
(40768804) Tissue Pathology biopsy report
120
982
1.40
1.97
2.5
2.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
30
184
1.71
1.88
8.4
3.9
kpa
5.6
5.9
1.05
30
179
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
40
2.56
1.85
1.8
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
17
3.58
1.84
1.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
17
3.58
1.84
6.7
1.6
ug/l
14.7
17.2
—
6
17
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
104
839
1.39
1.83
6.5
3.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
12
4.22
1.83
1.6
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
12
4.22
1.83
1.4
2.3
u/ml
1328.8
676.2
—
5
12
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
12
4.22
1.83
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
59
429
1.48
1.83
5.1
3.4
ng/l
929.3
185.8
0.40
47
328
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
230
2126
1.55
1.80
7.2
4.9
mu/l
1.8
2.5
0.59
212
1930
(3022145) Colonoscopy Study observation
42
285
1.56
1.79
1.2
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
24
2.97
1.73
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
212
0.45
1.73
1.7
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
19
3.20
1.67
1.0
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
27
167
1.69
1.66
12.2
7.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
42
291
1.52
1.64
1.9
2.1
ug/g
147.8
107.8
0.55
32
233
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
28
176
1.66
1.62
2.7
2.6
—
6.3
—
0
7
(4027681)
5
14
3.62
1.62
1.8
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
14
3.62
1.62
1.8
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
15
3.38
1.53
2.0
1.2
mmol/l
2.6
1.9
—
5
15
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
21
2.90
1.51
2.0
2.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
21
2.90
1.51
1.7
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
21
2.90
1.51
1.0
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
37
2.48
1.49
1.3
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
37
2.48
1.49
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
37
2.48
1.49
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
37
2.48
1.49
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
37
2.48
1.49
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
37
2.48
1.49
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
37
2.48
1.49
1.3
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
45
2.27
1.48
1.4
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
35
239
1.53
1.46
1.5
1.8
%
1.5
1.5
0.15
28
212
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
28
2.54
1.46
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
53
396
1.42
1.43
1.7
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
75
1.91
1.37
2.1
1.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
20
121
1.71
1.35
6.7
8.2
%
95.0
94.3
0.37
20
121
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
153
1352
1.30
1.34
3.1
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
48
2.13
1.29
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
55
2.04
1.29
1.5
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
115
0.42
1.28
1.6
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
44
2.08
1.28
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
44
2.08
1.28
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
74
596
1.33
1.26
5.8
3.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
25
2.43
1.25
1.5
1.9
%
92.7
90.2
—
6
25
(3044290) Cell count panel - Cerebral spinal fluid
9
45
2.03
1.24
2.1
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
36
258
1.46
1.22
7.4
6.1
mmol/l
104.0
103.8
0.09
36
251
(3000492) Spirometry study
30
207
1.51
1.21
2.0
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
26
174
1.55
1.21
2.3
2.9
u/ml
39.2
46.9
0.12
26
168
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
57
1.97
1.18
1.2
1.3
—
—
—
0
0
(4146454)
5
20
2.53
1.15
2.0
2.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
144
1.57
1.13
1.5
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
61
486
1.33
1.12
7.2
4.1
kg/l
1.0
1.0
0.05
15
61
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
147
0.53
1.07
1.5
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
23
155
1.53
1.05
5.1
2.7
kpa
4.5
4.4
0.13
23
150
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
5
22
2.30
1.04
1.2
2.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
22
2.30
1.04
1.0
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
22
2.30
1.04
2.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
7
34
2.09
1.03
1.1
1.1
—
2.6
—
0
13
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
27
2.25
0.94
1.7
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
27
2.25
0.94
5.0
17.7
mmol/l
7.7
7.0
—
6
21
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
27
2.25
0.94
1.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
52
1.76
0.93
1.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
206
0.61
0.93
1.2
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
169
1.46
0.91
2.6
2.5
ml/min/173m2
54.2
67.7
1.12
14
68
(4281824)
6
29
2.09
0.90
1.3
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
31
1.96
0.85
1.5
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
30
225
1.38
0.82
3.8
2.2
u/l
33.0
29.2
0.62
25
195
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
6
32
1.89
0.82
1.5
1.3
nmol/l
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
32
243
1.36
0.82
2.1
2.2
umol/l
3.9
7.8
3.23
26
210
(40768800) Prostate Pathology biopsy report
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
59
1.72
0.77
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
56
1.63
0.73
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
25
2.02
0.73
1.6
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
101
1.51
0.72
11.2
7.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
442
1.25
0.70
1.6
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
102
1.50
0.69
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
1.6
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
224
2150
1.25
0.66
26.1
12.6
ml/min/173m2
75.1
80.0
2.15
203
1747
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
173
1.36
0.64
1.2
1.2
iu/ml
229.6
180.4
—
7
74
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
88
1.50
0.62
1.2
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
5
30
1.68
0.61
1.0
1.0
—
0.2
—
0
6
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
131
1.40
0.61
1.5
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3020891) Body temperature
11
72
1.55
0.60
3.0
4.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
22
0.00
0.59
0.0
2.5
—
13.6
—
0
22
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
37
1.64
0.56
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
213
2045
1.20
0.55
29.2
14.1
%
36.7
39.8
2.98
135
1508
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
98
0.60
0.53
2.0
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
45
1.57
0.49
1.1
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
228
2213
1.19
0.45
5.5
4.6
mmol/l
6.0
5.9
0.25
207
2024
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
16
0.00
0.41
0.0
3.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
88
1.38
0.40
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
88
1.38
0.40
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
247
2512
0.80
0.39
47.2
19.6
fl
91.3
91.2
0.16
247
2471
(3049717) Cytology report of Urine Cyto stain
11
82
1.36
0.34
1.5
2.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
92
1.32
0.32
1.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
156
1.23
0.32
4.5
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
185
1.21
0.30
1.8
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
24
204
1.19
0.30
1.8
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
8
64
1.26
0.27
1.8
1.4
—
245.6
—
0
29
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
64
1.26
0.27
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
73
0.68
0.26
1.8
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
38
1.32
0.23
1.2
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
155
1601
0.93
0.23
5.7
3.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
39
1.29
0.23
2.2
2.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
2.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
50
1.20
0.20
7.3
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
216
2122
1.09
0.19
7.6
5.7
mmol/mol
40.3
39.7
0.42
197
1970
(4034850)
5
67
0.74
0.17
45.0
10.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
316
0.91
0.15
3.9
4.7
%
26.0
21.6
0.64
14
155
(40768793) Breast Pathology biopsy report
7
87
0.80
0.15
1.6
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
22
243
0.90
0.14
3.7
3.0
ug/l
0.8
0.7
0.17
17
150
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
8
96
0.83
0.14
5.9
2.4
%
0.6
0.7
—
8
96
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
28
257
1.10
0.14
2.6
4.2
ug/l
3.2
24.2
0.70
22
215
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
100
0.79
0.14
5.9
2.3
%
1.1
1.1
—
8
100
(3025941) Bacteria identified in Stool by Culture
15
132
1.14
0.13
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
114
1.15
0.12
3.2
2.5
—
—
—
0
0
(1002224) Polysomnography panel
11
95
1.16
0.12
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
30
279
1.08
0.11
1.3
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
218
2156
1.06
0.10
4.7
3.9
mmol/l
1.4
1.3
1.54
194
1969
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
46
1.09
0.09
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
87
1.16
0.09
1.3
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
226
2240
1.05
0.08
5.1
4.4
mmol/l
1.5
1.5
1.43
205
2061
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
65
0.76
0.08
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
64
1.10
0.08
1.3
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
64
1.10
0.08
2.6
3.8
mmol/l
3.5
3.8
—
7
57
(3000764) Benzodiazepines [Presence] in Urine
7
64
1.10
0.08
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
64
1.10
0.08
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
232
2302
1.06
0.08
5.6
5.0
mmol/l
2.7
2.8
1.32
210
2114
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
225
0.93
0.07
1.9
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
55
564
0.97
0.04
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
17
180
0.94
0.04
1.6
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
227
2258
1.03
0.04
5.1
4.4
mmol/l
4.6
4.8
1.40
206
2086
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
118
0.93
0.03
1.2
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
101
0.99
0.00
2.5
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
66
661
1.00
0.00
1.6
1.6
mmol/l
1.8
1.4
0.62
55
560
(40761511) CBC panel - Blood by Automated count
237
2373
0.99
0.00
30.1
12.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
64
0.94
0.00
1.3
1.3
—
—
—
0
0
(4094501)
6
60
1.00
0.00
1.2
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
20.1
—
0
7
(3043410) Blood group antigens tested for on Red Blood Cells
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
59
1.02
0.00
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
84
0.95
0.00
1.5
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
76
0.92
0.00
1.4
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
51
0.98
0.00
1.4
1.9
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
140
1.00
0.00
1.1
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_MYOMUSCINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MYOMUSCINOTH | 2.496 [2.04, 3.06] | < 0.001 |
| Birth year | 1.002 [0.99, 1.01] | 0.715 |
During the follow-up period (1.1.1998 — 31.12.2019), 313 out of 874 females with G6_MYOMUSCINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MYOMUSCINOTH | 2.303 [1.64, 3.22] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 124 out of 312 males with G6_MYOMUSCINOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_MYOMUSCINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.284% | 0.376% |
| 5 | 1.534% | 2.586% |
| 10 | 3.878% | 6.089% |
| 15 | 7.889% | 11.542% |
| 20 | 14.235% | 18.932% |
Relationships between endpoints
↥Index endpoint: G6_MYOMUSCINOTH – Disorders of myoneural junction and muscle in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data